Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.

Luo M, Zhu J, Yang Y, Liao C, Liu X, Tang M, Xu L, Zhong X, Ma Q, Guo X

Open source

DOI
10.3389/fphar.2025.1689663
Published
2025
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1689663,
  title = {Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.},
  author = {Luo M and Zhu J and Yang Y and Liao C and Liu X and Tang M and Xu L and Zhong X and Ma Q and Guo X},
  year = {2025},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2025.1689663},
  url = {https://doi.org/10.3389/fphar.2025.1689663}
}

RIS

TY  - JOUR
TI  - Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.
AU  - Luo M
AU  - Zhu J
AU  - Yang Y
AU  - Liao C
AU  - Liu X
AU  - Tang M
AU  - Xu L
AU  - Zhong X
AU  - Ma Q
AU  - Guo X
PY  - 2025
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2025.1689663
UR  - https://doi.org/10.3389/fphar.2025.1689663
ER  - 

APA

M, L., J, Z., Y, Y., C, L., X, L., M, T., L, X., X, Z., Q, M., & X, G. (2025). Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2025.1689663

Source records